Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|June 11, 1997
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assayC Scheibenbogen, K H Lee, S Stevanovic, et al.Cancer Research|June 19, 2001
Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion moleculeA Trojan, M Witzens, J L Schultze, et al.Annals of Hematology|March 22, 2002
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantationC Gemmel, F W Cremer, M Weis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-upM Kornacker, J Stumm, C Pott, et al.Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2015
Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphomaJ Meissner, D Tichy, V Katzke, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2014
Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHLN Murawski, M Pfreundschuh, S Zeynalova, et al.Leukemia|March 14, 2015
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaG Hess, U Keller, C W Scholz, et al.Annals of Hematology|August 17, 2012
Excellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospitalM Hensel, J Brust, C Plöger, et al.Annals of Hematology|August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meetingM Witzens-Harig, G Hess, J Atta, et al.Pageof 3